Market Tracker

04/24 4:40pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

2.16
Delayed Data
As of Apr 24
 +0.14 / +6.93%
Today’s Change
1.93
Today|||52-Week Range
3.84
+1.89%
Year-to-Date

Today’s Trading

Previous close2.02
Today’s open2.06
Day’s range2.05 - 2.17
Volume2,185,163
Average volume (3 months)2,034,134
Market cap$334.4M
Dividend yield9.26%
Data as of 3:59pm ET, 04/24/2017

Growth & Valuation

Earnings growth (last year)-80.79%
Earnings growth (this year)-66.67%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)-59.03%
P/E ratio5.5
Price/Sales1.45
Price/Book0.45

Competitors

 Today’s
change
Today’s
% change
BTXBioTime Inc+0.07+2.24%
SYRSSyros Pharmaceutical...+0.39+2.62%
RIGLRigel Pharmaceutical...+0.08+2.79%
IMGNImmunoGen Inc+0.08+1.99%
Data as of 4:00pm ET, 04/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$0.05
Annual revenue (last year)$239.7M
Annual profit (last year)$63.6M
Net profit margin26.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts